Antigenesis joins the AHA portfolio with a focus on creating targeted antibody-based cancer treatments for pets. With early funding secured and lead molecules in preclinical development, the company is working to bring new options to a fast-growing area of veterinary medicine.
We are delighted to congratulate SageTech Medical, one of our portfolio companies, on securing £3.6 million in funding through Innovate UK's prestigious Grand Challenge programme.
Antimicrobial resistance (AMR) is one of the defining challenges of our time. It affects animal health and welfare in practice and has profound potential consequences for human health. As vets, we understand the pressure to reduce reliance on antibiotics while still safeguarding our patients. Animal Health Angels, a group of veterinary and animal health professionals supporting early-stage innovation, has announced recent backing for three companies developing practical solutions to tackle AMR and antibiotic use in clinical settings: Zonova, FluoretiQ and NoBACZ.
Marleybones, the UK’s premium dog-nutrition brand behind Pantry Fresh® meals, has closed a £2.5M funding round, and we’re proud to have taken part!
In a landmark moment for the veterinary industry, Molly Fiander, a Registered Veterinary Nurse (RVN) and founder of Management For Locums (MFL), has become the first vet nurse in the UK to secure investment as a solo founder for a veterinary technology company. This pioneering achievement marks a shift in how veterinary professionals are leading innovation in the sector.
Celebrating Global Entrepreneurship Week, Animal Health Angels is thrilled to announce its investment in SageTech Medical, which is at the forefront of innovative technology aimed at tackling environmental challenges associated with anaesthetic gas emissions.
